NINJ1 and MMP9: potential biomarkers for intracranial atherosclerosis plaque vulnerability
NINJ1 and MMP9 can serve as independent predictors factors for intracranial atherosclerotic plaque enhancement, severe stenosis, and positive remodeling. NINJ1 and MMP9 have the potential to be serum biomarkers for the vulnerability of intracranial atherosclerotic plaques.
Authors
- Xiaolian Wei
- Yuge Zhang (ORCID: https://orcid.org/0000-0001-9756-3050)
- Ruifang Yan (ORCID: https://orcid.org/0000-0002-8122-4932)
- Xin Da (ORCID: https://orcid.org/0000-0002-1017-443X)
- Hua Zhong (ORCID: https://orcid.org/0000-0001-5593-7077)
- Ziang Li (ORCID: https://orcid.org/0000-0003-1262-9810)
- Bingjie Liu (ORCID: https://orcid.org/0000-0002-7115-8695)
- Bin Yuan (ORCID: https://orcid.org/0009-0009-3177-5478)
Institutions
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fneur.2025.1552948
- Citations
- 5
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 7.59